The role of basal ganglia in the control of generalized absence seizures
暂无分享,去创建一个
C. Deransart | A. Depaulis | C. Marescaux | L. Vercueil | L Vercueil | C Deransart | C Marescaux | A Depaulis
[1] M. Starr,et al. Anticonvulsant effect of striatal dopamine D2 receptor stimulation: Dependence on cortical circuits? , 1991, Neuroscience.
[2] C. Gerfen,et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.
[3] M. Bureau,et al. A Study of the Rhythm of Petit Mai Absences in Children in Relation to Prevailing Situations: The Use of EEG Telemetry during Psychological Examinations, School Exercises and Periods of Inactivity , 1969, Epilepsia.
[4] W. Turski,et al. Dopamine-sensitive anticonvulsant site in the rat striatum , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[5] Douglas L. Jones,et al. From motivation to action: Functional interface between the limbic system and the motor system , 1980, Progress in Neurobiology.
[6] H. Fibiger,et al. Dopaminergic correlates of motivated behavior: importance of drive , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[7] R. Jung. Blocking of Petit‐mal Attacks by Sensory Arousal and Inhibition of Attacks by an Active Change in Attention during the Epileptic Aura * , 1962 .
[8] B. Meldrum,et al. Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra. , 1984, European journal of pharmacology.
[9] J. Deniau,et al. Disinhibition as a basic process in the expression of striatal functions. I. The striato-nigral influence on tecto-spinal/tecto-diencephalic neurons , 1985, Brain Research.
[10] F. Bloom,et al. Cellular and molecular mechanisms of drug dependence. , 1988, Science.
[11] L. Danober,et al. Pathophysiological mechanisms of genetic absence epilepsy in the rat , 1998, Progress in Neurobiology.
[12] B. Bioulac,et al. Responses of substantia nigra pars reticulata neurons to intrastriatal D1 and D2 dopaminergic agonist injections in the rat , 1996, Neuroscience Letters.
[13] G. Aghajanian,et al. Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra , 1978, Brain Research.
[14] H. Kita,et al. Intracellular study of rat substantia nigra pars reticulata neurons in an in vitro slice preparation: electrical membrane properties and response characteristics to subthalamic stimulation , 1987, Brain Research.
[15] U. Wahnschaffe,et al. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats , 1991, Brain Research.
[16] A. Afifi,et al. Topical Review: Basal Ganglia: Functional Anatomy and Physiology. Part 2 , 1994, Journal of child neurology.
[17] M. Starr,et al. The role of dopamine in epilepsy , 1996, Synapse.
[18] E. Niedermeyer,et al. Primary (Idiopathic) Generalized Epilepsy and Underlying Mechanisms , 1996, Clinical EEG.
[19] M. Le Moal,et al. Mesocorticolimbic dopaminergic network: functional and regulatory roles. , 1991, Physiological reviews.
[20] E. Cavalheiro,et al. Intrastriatal N-methyl-d-aspartate prevents amygdala kindled seizures in rats , 1986, Brain Research.
[21] J. Gusella,et al. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] Z. Bortolotto,et al. Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[23] O. Hassani,et al. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states , 1997, Neuroscience.
[24] A. Depaulis,et al. Relationship between spike-wave discharges and vigilance levels in rats with spontaneous petit mal-like epilepsy , 1988, Neuroscience Letters.
[25] A. Phillips,et al. Dynamic Changes in Nucleus Accumbens Dopamine Efflux During the Coolidge Effect in Male Rats , 1997, The Journal of Neuroscience.
[26] K. Hsu,et al. Presynaptic D2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum , 1995, Brain Research.
[27] A. Depaulis,et al. Evidence that activation of GABA receptors in the substantia nigra suppresses spontaneous spike-and-wave discharges in the rat , 1988, Brain Research.
[28] A. Depaulis,et al. Are rats with genetic absence epilepsy behaviorally impaired? , 1991, Epilepsy Research.
[29] J. Csernansky,et al. Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala , 1988, Biological Psychiatry.
[30] B. Meldrum,et al. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: Effects of intranigral 2-amino-7-phosphonoheptanoate and n-methyl-d-aspartate , 1986, Neuroscience.
[31] A. Depaulis,et al. Effects of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures , 1988, Neuropharmacology.
[32] K. Gale,et al. Substantia nigra-mediated anticonvulsant actions: Role of nigral output pathways , 1987, Experimental Neurology.
[33] G. E. Alexander,et al. Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.
[34] S. Moshé,et al. Age‐Dependent Differences in the Anticonvulsant Effects of 2–Amino‐7‐Phosphono‐Heptanoic Acid or Ketamine Infusions Into the Substantia Nigra of Rats , 1992, Epilepsia.
[35] A. Graybiel,et al. Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin , 1990, Neuroscience.
[36] J. Mink. THE BASAL GANGLIA: FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMS , 1996, Progress in Neurobiology.
[37] Abdelhamid Benazzouz,et al. Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data , 1995, Neuroscience Letters.
[38] Intratectal glutamate suppresses pentylenetetrazole-induced spike-and-wave discharges. , 1988, European journal of pharmacology.
[39] A. Depaulis,et al. Suppression of spontaneous generalized non-convulsive seizures in the rat by microinjection of GABA antagonists into the superior colliculus , 1990, Epilepsy Research.
[40] P. Calabresi,et al. The neostriatum beyond the motor function: experimental and clinical evidence. , 1997, Neuroscience.
[41] P. Robledo,et al. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data , 1990, Brain Research.
[42] A. D. Smith,et al. The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat , 1996, Neuroscience.
[43] T. Dawson,et al. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase , 1988, Brain Research Bulletin.
[44] W. Nauta,et al. Efferent connections of the substantia nigra and ventral tegmental area in the rat , 1979, Brain Research.
[45] Stephen J. Fink,et al. Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons , 1993, Brain Research.
[46] J. Joyce,et al. Quantitative autoradiography of dopamine D2 sites in rat caudate-putamen: Localization to intrinsic neurons and not to neocortical afferents , 1987, Neuroscience.
[47] A. Depaulis,et al. Genetic absence epilepsy in rats from Strasbourg--a review. , 1992, Journal of neural transmission. Supplementum.
[48] J. Deniau,et al. Position of the ventral pallidum in the rat prefrontal cortex–basal ganglia circuit , 1997, Neuroscience.
[49] J. Lauterborn,et al. Cell-specific modulation of basal and seizure-induced neurotrophin expression by adrenalectomy , 1995, Neuroscience.
[50] S L Moshé,et al. Subthalamic nucleus: a new anticonvulsant site in the brain. , 1996, Neuroreport.
[51] G. Mogenson,et al. Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens , 1989, Brain Research.
[52] C. Deransart,et al. Involvement of nigral glutamatergic inputs in the control of seizures in a genetic model of absence epilepsy in the rat , 1996, Neuroscience.
[53] R. Maggio,et al. Blockade of GABA receptors in superior colliculus protects against focally evoked limbic motor seizures , 1993, Brain Research.
[54] R. Maggio,et al. Seizures evoked from area tempestas are subject to control by GABA and glutamate receptors in substantia nigra , 1989, Experimental Neurology.
[55] J. Salamone. The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine , 1996, Journal of Neuroscience Methods.
[56] J. Walters,et al. Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum , 1996, Neuroscience.
[57] Z. Bortolotto,et al. Review: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: A novel experimental model of intractable epilepsy , 1989, Synapse.
[58] U. Ungerstedt,et al. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat—II. Evidence for striataln-methyl-d-aspartate receptor regulation of striatonigral gabaergic transmission and motor function , 1996, Neuroscience.
[59] G. Robertson,et al. D1 and D2 dopamine receptors differentially increase fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain , 1995, Neuroscience.
[60] Garrett E. Alexander. Basal ganglia , 1998 .
[61] O. Phillipson,et al. The topographic order of inputs to nucleus accumbens in the rat , 1985, Neuroscience.
[62] M. Starr. Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease , 1995, Synapse.
[63] A. A. Jensen,et al. The dopamine D1 receptor family: structural and functional aspects. , 1996, Biochemical Society transactions.
[64] M. Starr,et al. D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra , 1991, Pharmacology Biochemistry and Behavior.
[65] Antoine Depaulis,et al. Endogenous control of epilepsy: The nigral inhibitory system , 1994, Progress in Neurobiology.
[66] R. Huff. Signal transduction pathways modulated by the D2 subfamily of dopamine receptors. , 1996, Cellular signalling.
[67] W. Löscher,et al. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations , 1988, Epilepsy Research.
[68] A. Depaulis,et al. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents , 1989, Brain Research.
[69] B. Bloch,et al. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[70] G. Paxinos. The Rat nervous system , 1985 .
[71] A. Graybiel. Neurotransmitters and neuromodulators in the basal ganglia , 1990, Trends in Neurosciences.
[72] U. Ungerstedt,et al. Intrastriatally injected c-fos antisense oligonucleotide interferes with striatonigral but not striatopallidal gamma-aminobutyric acid transmission in the conscious rat. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[73] A. Thierry,et al. Motor and Cognitive Functions of the Prefrontal Cortex , 1994, Research and Perspectives in Neurosciences.
[74] H. Groenewegen,et al. Anatomical Relationships Between the Prefrontal Cortex and the Basal Ganglia in the Rat , 1994 .
[75] D. Surmeier,et al. Dopamine receptor subtypes colocalize in rat striatonigral neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[76] J. Deniau,et al. Disinhibition as a basic process in the expression of striatal functions , 1990, Trends in Neurosciences.
[77] E. van Luijtelaar,et al. Sleep deprivation and spike-wave discharges in epileptic rats. , 1995, Sleep.
[78] B. Bloch,et al. D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum , 1995, The Journal of comparative neurology.
[79] D. Joel,et al. The organization of the basal ganglia-thalamocortical circuits: Open interconnected rather than closed segregated , 1994, Neuroscience.
[80] K. Gale. Mechanisms of seizure control mediated by gamma-aminobutyric acid: role of the substantia nigra. , 1985, Federation proceedings.
[81] H. Rosenberg,et al. Anti-pentylenetetrazol effect of intranigral 2-amino-7-phosphonoheptanoate attenuated by muscimol , 1991, Brain Research.
[82] Jean Féger,et al. The Effects of Activation or Inhibition of the Subthalamic Nucleus on the Metabolic and Electrophysiological Activities Within the Pallidal Complex and Substantia Nigra in the Rat , 1991, The European journal of neuroscience.